Physician Assistant · Middletown, NY
NPI
1194814673
Since 2006
Specialty
Physician Assistant
Code 363A00000X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
75 Maltese Dr
Middletown, NY, 10940
Phone (845) 342-4774
Groups this clinician bills Medicare through
Medicare paid, 2024
$127K
18,119 services
Medicare patients, 2024
135
Average age 67
Drug cost, 2024
$437K
782 prescriptions
Company payments, 2025
$3,840
From 22 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Brandi B Aquino was code J0585 (injection, onabotulinumtoxina, 1 unit), 17,009 times for 32 patients. In total Brandi B Aquino billed 18,119 services in 48 codes, and Medicare paid $127K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-07-29.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0585 Injection, onabotulinumtoxina, 1 unit | Office | 17,009 | 32 | $4.70 | $80K |
| 99214 Office E&M - Established | Office | 184 | 109 | $86.58 | $16K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 127 | 82 | $11.18 | $1,420 |
| 99213 Office E&M - Established | Office | 110 | 51 | $54.57 | $6,002 |
| 64615 Musculoskeletal | Office | 96 | 32 | $105.09 | $10K |
| 64405 Musculoskeletal | Office | 37 | 18 | $37.90 | $1,402 |
| 64400 Musculoskeletal | Office | 37 | 18 | $108.32 | $4,008 |
| 64450 Musculoskeletal | Office | 36 | 18 | $37.92 | $1,365 |
| 36415 Venipuncture Blood Collection | Office | 34 | 28 | $7.99 | $272 |
| 86618 Immunoassay | Office | 32 | 16 | $16.69 | $534 |
| 85651 Clinical Chemistry | Office | 19 | 18 | $4.18 | $79.42 |
| 86140 Clinical Chemistry | Office | 17 | 17 | $5.08 | $86.36 |
| 85025 Blood Count | Office | 16 | 15 | $7.61 | $122 |
| 99204 Office E&M - New | Office | 12 | 12 | $96.63 | $1,160 |
By year: 2022 $135K for 21,103 services; 2023 $110K for 16,973 services; 2024 $127K for 18,119 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 34 | 28 | $7.99 | $272 |
| 86618 Immunoassay | 32 | 16 | $16.69 | $534 |
| 85651 Clinical Chemistry | 19 | 18 | $4.18 | $79.42 |
| 86140 Clinical Chemistry | 17 | 17 | $5.08 | $86.36 |
| 85025 Blood Count | 16 | 15 | $7.61 | $122 |
Medicare prescription drug claims, 2024
In 2024, the drug Brandi B Aquino prescribed most often to Medicare patients was Nurtec Odt (Rimegepant Sulfate), with 112 prescriptions and refills. In total Brandi B Aquino wrote 782 Medicare prescriptions that cost $437K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Nurtec Odt Rimegepant Sulfate | 112 | 113 | 36 | $130K |
| Gabapentin Generic | 78 | 92 | 27 | $583 |
| Memantine Hcl Generic | 51 | 57 | Under 11 | $399 |
| Ubrelvy Ubrogepant | 48 | 48 | 11 | $47K |
| Botox Onabotulinumtoxina | 45 | 127 | 14 | $57K |
| Emgality Pen Galcanezumab-Gnlm | 42 | 42 | Under 11 | $28K |
| Topiramate Generic | 39 | 45 | 12 | $169 |
| Qulipta Atogepant | 39 | 43 | Under 11 | $45K |
| Verapamil Er Verapamil Hcl | 27 | 27 | Under 11 | $300 |
| Sumatriptan Succinate Generic | 22 | 22 | Under 11 | $3,730 |
| Ajovy Autoinjector Fremanezumab-Vfrm | 20 | 22 | Under 11 | $16K |
| Meclizine Hcl Generic | 20 | 24 | 12 | $215 |
| Aimovig Autoinjector Erenumab-Aooe | 19 | 19 | Under 11 | $14K |
| Ondansetron Odt Ondansetron | 18 | 18 | Under 11 | $275 |
| Methylprednisolone Generic | 16 | 16 | 16 | $101 |
Brand drugs: 363 claims; generic drugs: 419 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Brandi B Aquino $3,840 ($3,840 in general payments such as food, travel and fees) from 22 companies. The largest payer was Abbvie Inc. with $1,734.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 71 | $1,734 |
| Teva Pharmaceuticals USA, Inc. TEVA | 15 | $277 |
| UCB, Inc. UCB.BR | 11 | $233 |
| Pfizer Inc. PFE | 18 | $231 |
| Collegium Pharmaceutical, Inc. COLL | 13 | $210 |
| Catalyst Pharmaceuticals, Inc. CPRX | 12 | $160 |
| SK Life Science, Inc. | 12 | $155 |
| Indivior Inc. INDV | 1 | $125 |
| Novo Nordisk Inc NVO | 1 | $125 |
| Neurelis, Inc. | 4 | $94.83 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.